📊 Statistics
- Analyst 1 Year Price Target:
-
- Upside/Downside from Analyst Target:
-
- Broker Call:
-
- Dividend Minimum 3 Year Yield:
0.00%
- EPS Growth Range (1Y):
<0%
- Net Income Growth Range (1Y):
<0%
- Revenue Growth Range (1Y):
<0%
-
Upcoming Earnings Date:
-
💰 Dividend History
Current year to date yield:
2.37%
📅 SGX Earnings Announcements for P8A
Cordlife Group Limited (P8A)
Market: SGX |
Currency: SGD
Address: 1 Kim Seng Promenade
Cordlife Group Limited, an investment holding company, provides cord blood banking services in Singapore, Hong Kong, India, Malaysia, the Philippines, and internationally. It operates in two segments, Banking and Diagnostics. The Banking segment collects, processes, banks, and tests biological materials, such as cord blood, lining, and tissue samples. The Diagnostics segment offers diagnostic testing services, such as newborn genetic and metabolic screenings; pediatric vision and ear screenings; pediatric allergen test; and genetic talent test services. The company also provides corneal lenticule banking, gut microbiome banking, and lifestyle genetic screening services for adults. In addition, it offers Moms Up, a mobile application that offers parenting resources, as well as sprouts for health, wellness, and lifestyle needs. Further, the company provides medical laboratory, marketing, and property investment services, as well as medical and pharmaceutical research and development and consulting services. Cordlife Group Limited was incorporated in 2001 and is based in Singapore.
Show more
📈 Cordlife Group Limited Historical Chart
🧾 Recent Financial Statement Analysis
January 14, 2026
Cordlife Group Limited – Update on Legal Claims (HC/OA 1365/2025) Cordlife Group Limited Issues Critical Update on Legal Claims Relating to Cord Blood Units (HC/OA 1365/2025) Key Points from the Announcement Legal Proceedings Update: Cordlife Group Limited ("Cordlife" or the…
January 14, 2026
Cordlife Group Limited: Detailed Regulatory Update on Licence Renewals and Operational Impact Cordlife Group Limited: Regulatory Update on Licence Renewals and Implications for Shareholders Summary of Key Developments Renewal of Singapore cord blood banking and human tissue banking licences, but…
December 3, 2025
Cordlife Group Faces S\$5.45 Million Lawsuit Over Damaged Cord Blood Units Cordlife Group Faces S\$5.45 Million Lawsuit Over Damaged Cord Blood Units Key Points from the Latest Update Lawsuit Filed: Cordlife Group Limited ("Cordlife") has announced the filing of Originating…
December 2, 2025
Cordlife Group Regulatory Update: Key Details for Investors Cordlife Group Limited Receives Regulatory Action Notice from Singapore MOH Date: 1 December 2025 Company: Cordlife Group Limited Event: Receipt of Notice of Regulatory Action, Significant Operational Restrictions Imposed Key Points from…
November 15, 2025
Cordlife Group Limited Q3 2025 Financial Results: Navigating Uncertainty Amid Regulatory and Operational Challenges Cordlife Group Limited, a major player in cord blood and tissue banking services, has released its condensed interim financial statements for the third quarter and nine…
November 15, 2025
Cordlife Group Limited: Q3 and 9M2025 Financial Results Analysis Cordlife Group Limited, a leading provider of cord blood and tissue banking services in Asia, released its condensed interim financial statements for the third quarter and nine months ended 30 September…
October 6, 2025
Cordlife Group Faces Licence Suspension and Uncertain Future: What Investors Need to Know Cordlife Group Faces Licence Suspension and Uncertain Future: What Investors Need to Know Key Points from the Latest Update on Cordlife’s Going Concern Assessment Cordlife Group Limited…
August 15, 2025
Cordlife Group Limited: Interim Financial Analysis for H1 2025 Cordlife Group Limited has released its condensed interim financial statements for the six months ended 30 June 2025. This report provides an in-depth analysis of the company's key financial metrics, performance…
🔎 View more in SGX corporate News 🔎 View more in SGX Financial statements
📰 Related News & Research
Showing results matched by any of: P8A, Cordlife Group Limited, Cordlife, CLGL SP, CORDLIFE GROUP LTD, CORDLIFE GROUP
January 14, 2026
Cordlife Group Limited – Update on Legal Claims (HC/OA 1365/2025) Cordlife Group Limited Issues Critical Update on Legal Claims Relating to Cord Blood Units (HC/OA 1365/2025) Key Points from the Announcement Legal Proceedings Update: Cordlife Group Limited ("Cordlife" or the…
January 14, 2026
Cordlife Group Limited: Detailed Regulatory Update on Licence Renewals and Operational Impact Cordlife Group Limited: Regulatory Update on Licence Renewals and Implications for Shareholders Summary of Key Developments Renewal of Singapore cord blood banking and human tissue banking licences, but…
December 3, 2025
Cordlife Group Faces S\$5.45 Million Lawsuit Over Damaged Cord Blood Units Cordlife Group Faces S\$5.45 Million Lawsuit Over Damaged Cord Blood Units Key Points from the Latest Update Lawsuit Filed: Cordlife Group Limited ("Cordlife") has announced the filing of Originating…
December 2, 2025
Cordlife Group Regulatory Update: Key Details for Investors Cordlife Group Limited Receives Regulatory Action Notice from Singapore MOH Date: 1 December 2025 Company: Cordlife Group Limited Event: Receipt of Notice of Regulatory Action, Significant Operational Restrictions Imposed Key Points from…
November 15, 2025
Cordlife Group Limited Q3 2025 Financial Results: Navigating Uncertainty Amid Regulatory and Operational Challenges Cordlife Group Limited, a major player in cord blood and tissue banking services, has released its condensed interim financial statements for the third quarter and nine…
November 15, 2025
Cordlife Group Limited: Q3 and 9M2025 Financial Results Analysis Cordlife Group Limited, a leading provider of cord blood and tissue banking services in Asia, released its condensed interim financial statements for the third quarter and nine months ended 30 September…
October 27, 2025
Breaking: Cordlife Group Faces Potential One-Year Suspension of Core Licence—Company Submits Written Representations to MOH Key Developments and Investor Implications Cordlife Group Limited, a leading cord blood banking company in Singapore, has made a significant announcement that could have substantial…
October 13, 2025
Cordlife Faces Licence Suspension Threat: MOH Extends Response Deadline Cordlife Faces Licence Suspension Threat: MOH Extends Response Deadline Amid Regulatory Turmoil Key Highlights MOH Intends to Suspend Cordlife’s Key Licence: Cordlife Group Limited has received official notice from Singapore’s Ministry…
October 6, 2025
Cordlife Group Faces Licence Suspension and Uncertain Future: What Investors Need to Know Cordlife Group Faces Licence Suspension and Uncertain Future: What Investors Need to Know Key Points from the Latest Update on Cordlife’s Going Concern Assessment Cordlife Group Limited…
October 1, 2025
Cordlife Faces One-Year Licence Suspension: MOH Flags Major Compliance Lapses and Tank Testing Failures Key Developments: Service Suspension, Tank Failures, and Financial Uncertainty Cordlife Group Limited, Singapore’s prominent cord blood banking company, has been rocked by a fresh regulatory blow…
August 15, 2025
Cordlife Group Limited: Interim Financial Analysis for H1 2025 Cordlife Group Limited has released its condensed interim financial statements for the six months ended 30 June 2025. This report provides an in-depth analysis of the company's key financial metrics, performance…